Is in patients with COPD , treatment with a combination of formoterol and ipratropium more effective than a combination of salbutamol and ipratropium : a 3-week , randomized , double-blind , within-patient , multicenter study?
In COPD patients requiring combination bronchodilator treatment, the addition of formoterol to regular ipratropium treatment is more effective than the addition of salbutamol.
Our data highlight Lipo-SP as a promising approach with therapeutic/preventive potential for ALI and fibrosis.